overall survival

You have access
Baseline Tumor Size as a Predictive and Prognostic Factor of Immune Checkpoint Inhibitor Therapy for Non-small Cell Lung Cancer
MASAHIRO KATSURADA, TATSUYA NAGANO, MOTOKO TACHIHARA, TATSUNORI KIRIU, KOICHI FURUKAWA, KIYOKO KOYAMA, TAKEHIRO OTOSHI, REINA SEKIYA, DAISUKE HAZAMA, DAISUKE TAMURA, KYOSUKE NAKATA, NAOKO KATSURADA, MASATSUGU YAMAMOTO, KAZUYUKI KOBAYASHI and YOSHIHIRO NISHIMURA

Anticancer Research February 2019, 39 (2) 815-825; DOI: https://doi.org/10.21873/anticanres.13180
You have access
Chronic Inflammation as a Potential Predictive Factor of Nivolumab Therapy in Non-small Cell Lung Cancer
MARTIN SVATON, MILADA ZEMANOVA, JANA SKRICKOVA, LENKA JAKUBIKOVA, VITEZSLAV KOLEK, JURAJ KULTAN, LEONA KOUBKOVA, ALZBETA BEJCKOVA, FRANTISEK SALAJKA, MICHAL HRNCIARIK, BOHUSLAV MELICHAR, DAVID VRANA, MAREK KONECNY, RENATA CHLOUPKOVA and MILOS PESEK

Anticancer Research December 2018, 38 (12) 6771-6782; DOI: https://doi.org/10.21873/anticanres.13048
You have access
Whole-Brain Radiotherapy (WBRT) for Brain Metastases: Does the Interval Between Imaging and Treatment Matter?
HEINKE C. HANSEN, STEFAN JANSSEN, CATHRIN THIEME, ALEKSEJ PERLOV, STEVEN E. SCHILD and DIRK RADES

Anticancer Research December 2018, 38 (12) 6835-6840; DOI: https://doi.org/10.21873/anticanres.13057
You have access
A Matched-Pair Study Comparing Surgery Plus Neoadjuvant Radio-Chemotherapy and Surgery Alone for High Rectal Cancers
DIRK RADES, RASMUS PEULICHE VOGELSANG, MAXI TREDER, STEFAN JANSSEN, STEVEN E. SCHILD, NIELS HENRIK HOLLÄNDER and ISMAIL GÖGENUR

Anticancer Research December 2018, 38 (12) 6877-6880; DOI: https://doi.org/10.21873/anticanres.13063
You have access
Primary Tumor Size Predicts Distant Metastasis of Mucosal Malignant Melanoma in Head and Neck
HIDENORI SUZUKI, GAKU TAKANO, NOBUHIRO HANAI, DAISUKE NISHIKAWA, YUSUKE KOIDE, SHINTARO BEPPU and YASUHISA HASEGAWA

Anticancer Research November 2018, 38 (11) 6485-6490; DOI: https://doi.org/10.21873/anticanres.13012
You have access
Prognostic Significance of Neutrophil–to–lymphocyte Ratio in the Framework of the 8th TNM Edition for Breast Cancer
PATRIZIA FERRONI, MARIO ROSELLI, ORESTE C. BUONOMO, ANTONELLA SPILA, ILARIA PORTARENA, ANASTASIA LAUDISI, MARIA G. VALENTE, SILVANA P. PIRILLO, LUCIO FORTUNATO, LEOPOLDO COSTARELLI, FRANCESCO CAVALIERE and FIORELLA GUADAGNI

Anticancer Research August 2018, 38 (8) 4705-4712; DOI: https://doi.org/10.21873/anticanres.12777
You have access
Preoperative Prognostic Nutritional Index Predicts Long-term Outcome in Gastric Cancer: A Propensity Score-matched Analysis
NORIYUKI HIRAHARA, YOSHITSUGU TAJIMA, YUSUKE FUJII, TETSU YAMAMOTO, RYOJI HYAKUDOMI, TAKAHITO TANIURA, SHUNSUKE KAJI and YASUNARI KAWABATA

Anticancer Research August 2018, 38 (8) 4735-4746; DOI: https://doi.org/10.21873/anticanres.12781
You have access
A New Scoring-system for Estimating Overall Survival After Radiotherapy of Recurrent Head and Neck Cancers
DIRK RADES, DANIEL SEIDL, STEFAN JANSSEN, SAMER G. HAKIM, BARBARA WOLLENBERG, TOBIAS BARTSCHT and STEVEN E. SCHILD

Anticancer Research March 2018, 38 (3) 1611-1613;
You have access
Two-step Intensity-modulated Radiation Therapy for Oropharyngeal Cancer: Initial Clinical Experience and Validation of Clinical Staging
HITOSHI TATEBE, HIROSHI DOI, KAZUKI ISHIKAWA, HISATO KAWAKAMI, MASAKI YOKOKAWA, KIYOSHI NAKAMATSU, SHUICHI KANAMORI, TORU SHIBATA, MUTSUKAZU KITANO and YASUMASA NISHIMURA

Anticancer Research February 2018, 38 (2) 979-986;
You have access
Prognostic Significance of Pancreatic Metastases from Renal Cell Carcinoma in Patients Treated with Tyrosine Kinase Inhibitors
PAWEL CHROM, RAFAL STEC, LUBOMIR BODNAR and CEZARY SZCZYLIK

Anticancer Research January 2018, 38 (1) 359-365;

Main menu

User menu

Search

overall survival

Pages